PT97976A - Processo de tratamento farmaco-tecnico de uma substancia activa, injectavel, com uma substancia suporte, nomeadamente coprosterol, acido glicocolico, colesterol ou esteres de colesterol, e de formulacoes parentericas - Google Patents

Processo de tratamento farmaco-tecnico de uma substancia activa, injectavel, com uma substancia suporte, nomeadamente coprosterol, acido glicocolico, colesterol ou esteres de colesterol, e de formulacoes parentericas

Info

Publication number
PT97976A
PT97976A PT97976A PT9797691A PT97976A PT 97976 A PT97976 A PT 97976A PT 97976 A PT97976 A PT 97976A PT 9797691 A PT9797691 A PT 9797691A PT 97976 A PT97976 A PT 97976A
Authority
PT
Portugal
Prior art keywords
cholesterol
carrier
drug
injectable
substance
Prior art date
Application number
PT97976A
Other languages
English (en)
Other versions
PT97976B (pt
Inventor
Josue Garza Flores
Juan Angeles Uribe
Original Assignee
Aplicaciones Farmaceuticas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmaceuticas filed Critical Aplicaciones Farmaceuticas
Publication of PT97976A publication Critical patent/PT97976A/pt
Publication of PT97976B publication Critical patent/PT97976B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PT97976A 1990-06-14 1991-06-14 Processo de tratamento farmaco-tecnico de uma substancia activa, injectavel, com uma substancia suporte, nomeadamente coprosterol, acido glicocolico, colesterol ou esteres de colesterol, e de formulacoes parentericas PT97976B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007417A FR2663224B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.

Publications (2)

Publication Number Publication Date
PT97976A true PT97976A (pt) 1992-04-30
PT97976B PT97976B (pt) 1998-11-30

Family

ID=9397599

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97976A PT97976B (pt) 1990-06-14 1991-06-14 Processo de tratamento farmaco-tecnico de uma substancia activa, injectavel, com uma substancia suporte, nomeadamente coprosterol, acido glicocolico, colesterol ou esteres de colesterol, e de formulacoes parentericas

Country Status (33)

Country Link
US (1) US5643604A (pt)
EP (1) EP0487674B1 (pt)
JP (1) JP2690398B2 (pt)
KR (1) KR0157438B1 (pt)
CN (1) CN1058608C (pt)
AT (1) ATE117546T1 (pt)
AU (1) AU643540B2 (pt)
BG (1) BG61178B1 (pt)
BR (1) BR9105782A (pt)
CA (1) CA2064861C (pt)
CZ (1) CZ286199B6 (pt)
DE (1) DE69107026T2 (pt)
DK (1) DK0487674T3 (pt)
ES (1) ES2068592T3 (pt)
FI (1) FI107697B (pt)
FR (1) FR2663224B1 (pt)
GR (1) GR3015809T3 (pt)
HU (1) HU219461B (pt)
IE (1) IE69172B1 (pt)
IL (1) IL98458A (pt)
NO (2) NO920576L (pt)
NZ (1) NZ238543A (pt)
PH (1) PH30243A (pt)
PL (1) PL167177B1 (pt)
PT (1) PT97976B (pt)
RO (1) RO110198B1 (pt)
RU (1) RU2095055C1 (pt)
SK (1) SK279867B6 (pt)
TN (1) TNSN91047A1 (pt)
TW (1) TW205511B (pt)
UY (1) UY23239A1 (pt)
WO (1) WO1991019485A1 (pt)
ZA (1) ZA914549B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6416778B1 (en) 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
WO2000057851A2 (en) 1999-03-26 2000-10-05 Pozen Inc. High potency dihydroergotamine compositions
DE19940795A1 (de) * 1999-08-27 2001-03-01 Lohmann Therapie Syst Lts Schnellzerfallende Pellets auf der Basis von Chitosan
EP1297756B1 (de) * 2001-09-27 2005-02-09 Cognis Deutschland GmbH & Co. KG Kugelförmige Sterinzubereitungen, deren Herstellung und Verwendung
AU2002336653A1 (en) * 2001-10-24 2003-05-06 Luciano Mastronardi Management of postoperative pain
JP2005513080A (ja) * 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド 薬物の膣送達
RU2205634C1 (ru) * 2002-06-18 2003-06-10 Нестерук Владимир Викторович Лекарственное средство, обладающее противорвотным действием
US7314859B2 (en) * 2002-12-27 2008-01-01 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
JP2006515026A (ja) * 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド 乳房の疾患および障害の処置のための薬学的調製物
CA2528545C (en) * 2003-06-13 2014-08-12 John Claude Savoir Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
SI1838716T1 (sl) 2005-01-05 2011-10-28 Lilly Co Eli Olanzapin pamoat dihidrat
WO2007072491A2 (en) * 2005-12-21 2007-06-28 Baskaran Chandrasekar Sustained release pharmaceutical formulation and treatment of ischemic heart disease by administering the same
EP2591675A1 (en) 2006-11-27 2013-05-15 H. Lundbeck A/S Heteroaryl amide derivatives
US20080153789A1 (en) * 2006-12-26 2008-06-26 Femmepharma Holding Company, Inc. Topical administration of danazol
CA2721509A1 (en) 2008-04-14 2009-10-22 Posi Visionary Solutions Llp Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
RU2395139C1 (ru) * 2009-04-10 2010-07-20 Российская Федерация, от имени которой выступает Государственная корпорация по атомной энергии "Росатом" Способ изготовления волновода переменного сечения
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
RU2012133627A (ru) * 2010-01-14 2014-04-20 Умекрине Муд Аб Фармацевтическая композиция, содержащая 3-бета-гидрокси-5-альфа-прегнан-20-он, с улучшенными свойствами хранения и растворимости
RU2576236C1 (ru) * 2014-08-22 2016-02-27 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2577689C1 (ru) * 2014-08-26 2016-03-20 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2578408C1 (ru) * 2014-09-10 2016-03-27 Александр Александрович Кролевец Способ получения нанокапсул алкалоидов
ITUB20153652A1 (it) * 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE744162A (fr) * 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd Procede d'encapsulage
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
DK123067B (da) * 1970-09-25 1972-05-15 Niro Atomizer As Fremgangsmåde til behandling af et pulverformigt, fedtholdigt mælkeprodukt.
JPS5017525A (pt) * 1973-06-14 1975-02-24
US3982537A (en) * 1974-12-30 1976-09-28 Louis Bucalo Dynamic implants and method for implanting the same
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
US4357259A (en) * 1977-08-01 1982-11-02 Northwestern University Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
FR2524312B1 (fr) * 1982-04-01 1985-10-04 Tech Cuir Centre Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif
US4492720A (en) * 1983-11-15 1985-01-08 Benjamin Mosier Method of preparing microspheres for intravascular delivery
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
JPS61174940A (ja) * 1985-01-29 1986-08-06 Oogawara Kakoki Kk ワックス類コーテイング単核状マイクロカプセルおよびその製造方法
US4675173A (en) * 1985-05-08 1987-06-23 Molecular Biosystems, Inc. Method of magnetic resonance imaging of the liver and spleen
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
EP0257368B1 (en) * 1986-08-11 1992-03-25 American Cyanamid Company Compositions for parenteral administration and their use
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US4748024A (en) 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
EP0357644B1 (en) * 1987-04-06 1994-08-17 Aberlyn Capital Management Limited Partnership Flash flow fused medicinal implants
EP0366058A3 (en) * 1988-10-27 1991-03-20 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
FR2663223B1 (fr) * 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.

Also Published As

Publication number Publication date
PH30243A (en) 1997-02-05
IL98458A (en) 1995-12-31
PT97976B (pt) 1998-11-30
RO110198B1 (ro) 1995-11-30
SK279867B6 (sk) 1999-04-13
TNSN91047A1 (fr) 1992-10-25
HUT61458A (en) 1993-01-28
DK0487674T3 (da) 1995-06-26
BG95911A (bg) 1993-12-24
DE69107026D1 (de) 1995-03-09
EP0487674B1 (fr) 1995-01-25
ES2068592T3 (es) 1995-04-16
NO302927B1 (no) 1998-05-11
ATE117546T1 (de) 1995-02-15
HU219461B (hu) 2001-04-28
UY23239A1 (es) 1991-07-12
FR2663224B1 (fr) 1995-01-20
CZ286199B6 (cs) 2000-02-16
NO920576D0 (no) 1992-02-13
IL98458A0 (en) 1992-07-15
BR9105782A (pt) 1992-08-18
NZ238543A (en) 1993-08-26
GR3015809T3 (en) 1995-07-31
FI920661A0 (fi) 1992-02-14
EP0487674A1 (fr) 1992-06-03
PL290678A1 (en) 1992-06-26
ZA914549B (en) 1992-03-25
IE69172B1 (en) 1996-08-07
NO920576L (no) 1992-04-08
CA2064861A1 (fr) 1991-12-15
AU8066791A (en) 1992-01-07
RU2095055C1 (ru) 1997-11-10
FI107697B (fi) 2001-09-28
FR2663224A1 (fr) 1991-12-20
JP2690398B2 (ja) 1997-12-10
CN1057960A (zh) 1992-01-22
CA2064861C (fr) 2000-08-01
KR0157438B1 (ko) 1998-11-16
CS181591A3 (en) 1992-06-17
CN1058608C (zh) 2000-11-22
AU643540B2 (en) 1993-11-18
WO1991019485A1 (fr) 1991-12-26
JPH05501268A (ja) 1993-03-11
KR920702212A (ko) 1992-09-03
IE912018A1 (en) 1991-12-18
US5643604A (en) 1997-07-01
PL167177B1 (pl) 1995-08-31
TW205511B (pt) 1993-05-11
DE69107026T2 (de) 1995-08-31
HU9200775D0 (en) 1992-05-28
BG61178B1 (bg) 1997-02-28

Similar Documents

Publication Publication Date Title
PT97976A (pt) Processo de tratamento farmaco-tecnico de uma substancia activa, injectavel, com uma substancia suporte, nomeadamente coprosterol, acido glicocolico, colesterol ou esteres de colesterol, e de formulacoes parentericas
ZA93929B (en) A process for the preparation of biologically active materialcontaining polymeric microcapsules.
GR3007481T3 (pt)
MY117810A (en) Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters.
EP0235603A3 (en) Process for forming uniform liquid droplets
EP0414007A3 (en) A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient
EP0601885A3 (en) Optically active biodegradable polymer of lactones and its production process.
DE68901938D1 (de) Polyamid-imid-loesungen und verfahren zu deren herstellung.
CA2149224A1 (en) Process for making partially aromatic polyamides containing 2-methylpentamethylenediamine units
HU904577D0 (en) Process for producing amides of carboxylic acid and pharmaceutical preparatives containing such active substance
EP0431188A4 (en) Method of modifying medical material based on lactate polymer
CA2054559A1 (en) Process of producing phosphatidylcholine derivatives
HUT61310A (en) Process for producing oxopyrrolo/2,3-b/indoleacetic acids, their esters, amides and derivatives, as well as pharmaceutical compositions comprising such compounds as active ingredient
HU908403D0 (en) Process for the production of amino-pyridinyl-methanol- and amino-methyl-pyridine-amin derivatives and medical compositions containing them as active agents
HU907627D0 (en) Process for producing diamides of pyridine-2,4 and 2,5-dicarboxylic acid and pharmaceutical preparatives containing these compounds as active substances
de Abajo et al. Thermally Stable Polymers. Current Research Trends. II. Modern Aromatic Polyester and Polyamide Synthesis Reactions
Inoue et al. Process for producing a shaped and drawn aromatic imide polymer article
HUT46693A (en) Process for producing dioxabicyclo/3,3,0/oktanon-oxim-ethers and pharmaceutical compositions containing them as active components
SU1790200A1 (ru) Способ получения поликапроамида
HU203343B (en) Process for producing new, optically active trans-1-ethyloctahydro-indolo(2,3-a)quinolizin-1-ylalkanecarboxylic acid amid derivatives and pharmaceutical compositions comprising same
CS22989A2 (en) Method of epsilon-caprolactam's modified polymers preparation

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920116

FG3A Patent granted, date of granting

Effective date: 19980805

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20120206